St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
-
New drug shows promise in High-Risk eye cancer trial
Disease control CompletedThis study tested a drug called darovasertib in 15 people with a high-risk eye cancer called uveal melanoma. Participants took the drug for up to 4 weeks before having their eye removed, and some continued treatment for 6 months after surgery. The goal was to see if the drug is s…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated May 27, 2026 12:02 UTC
-
Tiny trial aims to shed light on PSMA scans in hard-to-treat prostate cancer
Knowledge-focused CompletedThis study tested whether taking dasatinib alone or with darolutamide for 14 days can increase PSMA levels on PET scans in men with metastatic prostate cancer. Only 4 men participated, all with low PSMA uptake on their initial scan. The goal was to learn more about how PSMA expre…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Knowledge-focused
Last updated Jun 17, 2026 06:28 UTC